Reply to Torlakovic, E.; Normanno, N. Comment on “Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. <i>J. Mol. Pathol.</i> 2024, <i>5</i>, 1–10”

Gelijkaardige items

• Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management
  door: Kassandra R. Bisson, MHSc, et al.
  Gepubliceerd in: (2025-07-01)
• Reply to Torlakovic, E.; Normanno, N. Comment on “Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. <i>J. Mol. Pathol.</i> 2024, <i>5</i>, 1–10”
  door: Brandon S. Sheffield, et al.
  Gepubliceerd in: (2024-06-01)
• <i>ATM</i> Immunohistochemistry as a Tool to Identify and Classify Somatic <i>ATM</i> Variants in Prostate Cancer
  door: Roger Ferreira, et al.
  Gepubliceerd in: (2026-06-01)
• Challenges and improvements in HER2 scoring and histologic evaluation: insights from a national proficiency testing scheme for breast cancer diagnosis in China
  door: Xuemin Xue, et al.
  Gepubliceerd in: (2024-09-01)
• RAS-variant allele frequency as a potential prognostic marker of overall survival in patients with metastatic colorectal cancer
  door: Udit Nindra, et al.
  Gepubliceerd in: (2026-01-01)